[go: up one dir, main page]

BR9606890A - Uso de composto e processos para tratamento e a profilaxia de hiperlipoproteinemia hipertrigliceridemia hiperlipidemia ou hipercolesterolemia da arteriosclerose incluindo aterosclerose e para o tratamento e profilaxia anticoagulante de pacientes - Google Patents

Uso de composto e processos para tratamento e a profilaxia de hiperlipoproteinemia hipertrigliceridemia hiperlipidemia ou hipercolesterolemia da arteriosclerose incluindo aterosclerose e para o tratamento e profilaxia anticoagulante de pacientes

Info

Publication number
BR9606890A
BR9606890A BR9606890A BR9606890A BR9606890A BR 9606890 A BR9606890 A BR 9606890A BR 9606890 A BR9606890 A BR 9606890A BR 9606890 A BR9606890 A BR 9606890A BR 9606890 A BR9606890 A BR 9606890A
Authority
BR
Brazil
Prior art keywords
treatment
prophylaxis
hyperlipoproteinemia
hypertriglyceridemia
hypercholesterolemia
Prior art date
Application number
BR9606890A
Other languages
English (en)
Inventor
Michael Shalmi
Niels Korsgaard
Steven Bain
Birgitte Hjort Guldhammer
Jan Ulrik Weis
Charles E Hart
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of BR9606890A publication Critical patent/BR9606890A/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/3533,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrane Compounds (AREA)
BR9606890A 1995-01-13 1996-01-10 Uso de composto e processos para tratamento e a profilaxia de hiperlipoproteinemia hipertrigliceridemia hiperlipidemia ou hipercolesterolemia da arteriosclerose incluindo aterosclerose e para o tratamento e profilaxia anticoagulante de pacientes BR9606890A (pt)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
DK4195 1995-01-13
DK4395 1995-01-13
DK6995 1995-01-20
DK76695 1995-06-30
DK77795 1995-06-30
DK76795 1995-06-30
PCT/DK1996/000014 WO1996021443A1 (en) 1995-01-13 1996-01-10 Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of hyperlipoproteinaemia, hypertriglyceridaemia, hyperlipidaemia or hypercholesterolaemia or arteriosclerosis or for anticoagulative treatment

Publications (1)

Publication Number Publication Date
BR9606890A true BR9606890A (pt) 1997-10-28

Family

ID=27545138

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9606890A BR9606890A (pt) 1995-01-13 1996-01-10 Uso de composto e processos para tratamento e a profilaxia de hiperlipoproteinemia hipertrigliceridemia hiperlipidemia ou hipercolesterolemia da arteriosclerose incluindo aterosclerose e para o tratamento e profilaxia anticoagulante de pacientes

Country Status (11)

Country Link
EP (1) EP0804189A1 (pt)
JP (1) JPH10511961A (pt)
CN (1) CN1168098A (pt)
AU (1) AU4329296A (pt)
BR (1) BR9606890A (pt)
CA (1) CA2208859A1 (pt)
CZ (1) CZ212397A3 (pt)
HU (1) HUP9800521A3 (pt)
IL (1) IL116745A (pt)
NO (1) NO973241L (pt)
WO (1) WO1996021443A1 (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5407955A (en) * 1994-02-18 1995-04-18 Eli Lilly And Company Methods for lowering serum cholesterol and inhibiting smooth muscle cell proliferation, restenosis, endometriosis, and uterine fibroid disease
US6069175A (en) * 1996-11-15 2000-05-30 Pfizer Inc. Estrogen agonist/antagonists treatment of atherosclerosis
AU3023999A (en) * 1998-03-20 1999-10-18 Novo Nordisk A/S Use of 3,4-diphenylchromans for the manufacture of a pharmaceutical composition for lowering plasma levels of lp(a) in a human or sub-human primate
US6465445B1 (en) 1998-06-11 2002-10-15 Endorecherche, Inc. Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
US7005428B1 (en) 1998-06-11 2006-02-28 Endorecherche, Inc. Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
US6613083B2 (en) 2001-05-02 2003-09-02 Eckhard Alt Stent device and method
US8080675B2 (en) 2004-09-21 2011-12-20 Marshall Edwards, Inc. Chroman derivatives, medicaments and use in therapy
WO2006032085A1 (en) 2004-09-21 2006-03-30 Novogen Research Pty Ltd Substituted chroman derivatives, medicaments and use in therapy
EP2635273B1 (en) 2010-11-01 2020-01-08 MEI Pharma, Inc. Isoflavonoid compositions and methods for the treatment of cancer
CN105980372B (zh) 2014-02-07 2018-05-08 凯捷治疗有限公司 官能化的苯并吡喃化合物及其用途
AU2016215515B2 (en) 2015-02-02 2020-04-30 Mei Pharma, Inc. Combination therapies

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1543749A1 (de) * 1966-02-16 1969-12-11 Merck Ag E Verfahren zur Herstellung von 3,4-cis-4-Aryl-isoflavanen
US5407955A (en) * 1994-02-18 1995-04-18 Eli Lilly And Company Methods for lowering serum cholesterol and inhibiting smooth muscle cell proliferation, restenosis, endometriosis, and uterine fibroid disease

Also Published As

Publication number Publication date
WO1996021443A1 (en) 1996-07-18
HUP9800521A3 (en) 1999-12-28
IL116745A0 (en) 1996-05-14
MX9705214A (es) 1997-10-31
CZ212397A3 (en) 1997-11-12
JPH10511961A (ja) 1998-11-17
IL116745A (en) 1999-12-22
AU4329296A (en) 1996-07-31
HUP9800521A2 (hu) 1998-12-28
CN1168098A (zh) 1997-12-17
EP0804189A1 (en) 1997-11-05
CA2208859A1 (en) 1996-07-18
NO973241D0 (no) 1997-07-11
NO973241L (no) 1997-07-11

Similar Documents

Publication Publication Date Title
BR9504072A (pt) Composiçao farmacêutica métodos para o tratamento de hipercolesterolemia de aterosclerose e kit
FI943731L (fi) Polymeeriset ruuvit ja pinnoitteet kirurgisiin käyttöihin
DE69408640D1 (de) Wegwerfwindel
BR9606890A (pt) Uso de composto e processos para tratamento e a profilaxia de hiperlipoproteinemia hipertrigliceridemia hiperlipidemia ou hipercolesterolemia da arteriosclerose incluindo aterosclerose e para o tratamento e profilaxia anticoagulante de pacientes
DE69618170D1 (de) Wegwerfwindel
DE69619799D1 (de) Wegwerfwindel
KR970005253A (ko) 일회용 기저귀
DE69617646D1 (de) Wegwerfwindel
DE59606242D1 (de) Wegwerfwindel
PT93791A (pt) Dispositivo para tratamento de residuos medicos especiais
DE69626079D1 (de) Wegwerfwindel
DE69618732D1 (de) Wegwerfwindel
FI910893A7 (fi) DADMAC-pitoisten polymeerien käyttö päällystetyn hylkypaperin käsittelyssä
NO952820D0 (no) Behandling av avfallspetroleum
FI942908A7 (fi) Uusia BHT-eetteriyhdisteitä ja niiden käyttö hyperlipidemian ja ateros kleroosin vastaisina lääkkeinä
BR9510554A (pt) Uso de moléculas de ligação de mch-ii e/ou moléculas de imitação para a prevenção e/ou tratamento de doenças inflamatórias
DE59610263D1 (de) Kosmetische und/oder pharmazeutische Emulsionen
FI912160A7 (fi) Koostumus luun huokoistumisen ja hormonitasapainottomuuden hoitamiseksi
BR9611838A (pt) Compostos úteis para a enibição de replicação de HIV-1 E mutantes de HIV-1
DE59607760D1 (de) Kosmetische und/oder pharmazeutische Emulsionen
PT751775E (pt) Derivados de mercaptoacetilamida hipocolesterolemicos, antiateroscleroticos e hipotrigliceridemicos
DE59607818D1 (de) Kosmetische und/oder pharmazeutische Emulsionen
DE59601180D1 (de) Kosmetische und/oder pharmazeutische Emulsionen
DE59611512D1 (de) Kosmetische und/oder pharmazeutische Emulsionen
KR960026719U (ko) 일회용 기저귀

Legal Events

Date Code Title Description
EG Technical examination (opinion): publication of technical examination (opinion)
FC Decision: refusal